1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Anti-Infective Drug News 12 JANUARY 2015

Anti-Infective Drug News 12 JANUARY 2015

  • January 2015
  • -
  • Espicom Business Intelligence
  • -
  • 24 pages

Industry Trend Analysis - High NME FDA Approvals In 2014 Indicates New Era For Anti-Infectives
Industry Brief - Xydalba Gains CHMP Positive Opinion For ABSSSIs In Adults
Industry Brief - Zevtera Gains Swissmedic Approval For Pneumonia
Industry Brief - Phylogica/Genentech Enter Collaboration For Novel Antibiotics
Industry Brief - Positive Results Reported From FoamOtic Externa Phase II Trial In AOE
Industry Trend Analysis - Plazomicin QIDP Designation Highlights Achaogen As Acquisition Target
Industry Brief - Taiho Receives Approval To Manufacture And Market Zosyn 4.5 For IV Infusion Bag
Industry Brief - Cempra Announces Positive Top-Line Phase III Results For Oral Solithromycin In CABP
Industry Brief - Sagent Launches Colistimethate For Injection In US
Industry Brief - Positive Results For Capitol-Enabled Delafloxacine IV In First Phase III Trial For ABSSSIs
Industry Brief - Ferrer Licenses Ozenoxacin Commercialisation Rights In Canada To Cipher
Industry Brief - Debiopharm's Debio 1450 Gains FDA Fast Track Designation
Industry Brief - FDA Approves Cubist's Zerbaxa For cUTIs and cIAIs
Industry Trend Analysis - AbbVie HCV Approval Places Pressure On Gilead To Change Attitude To Drug Pricing
Industry Brief - Express Scripts Covers AbbVie's Viekira Pak For HCV But Excludes Harvoni/Sovaldi
Industry Brief - Gilead/CVS Team Up For HCV Drugs
Industry Brief - Health Canada Approves AbbVie's Holkira Pak For cHCV GT1
Industry Brief - FDA Approves BioCryst's Rapivab For Acute Uncomplicated Flu
Industry Brief - Enrolment Completed In GEN-003 Phase II Dose Optimisation Trial In Genital Herpes
Industry Brief - J&J Commences Phase I Trial of Ebola Vaccine Regimen In UK
Industry Brief - Tekmira Signs Deal To Provide TKM-Ebola-Guinea For Clinical Studies In West Africa
Industry Brief - NewLink/Merck Awarded BARDA Contract To Support Development Of Ebola Vaccine Candidate
Industry Brief - Cytos Licenses VLP Platform For Hepatitis B Infections To OnCore Biopharma
Industry Brief - Eiger's Lonafarnib Gains ODD In US/Europe For HDV
Industry Brief - EB Pharma Licenses Tipifarnib From Janssen For Development In HDV
Industry Brief - Gilead/Janssen Expand Collaboration For TAF-Based Single-Tablet HIV Regimens
Industry Brief - Lupin Gains Darunavir Tentative Approval
Industry Brief - Mylan Selected As ARV Drugs Supplier For 2015-2018 In South Africa
Industry Brief - Lupin Gains US Lamivudine Approval
Industry Trend Analysis - South African ARV Tender Will Increase Rewards And Pressure On Generic Firms
Industry Trend Analysis - An Update On Diseases Of The Developing World: Malaria, TB And HIV/AIDS
Industry Brief - 3-V Completes Series D Fundraising
Industry Brief - Dynavax Raises Funds To Advance Heplisav-B Development

Table Of Contents

Anti-Infective Drug News 12 JANUARY 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.